Yellow fever: 100 Years of discovery

JAMA

Volumn 300, Issue 8, 2008, Pages 960-962

  Staples, J Erin ^a   Monath, Thomas P ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Kleiner Perkins Caufield & Byers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17D VACCINE; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

AEDES AEGYPTI; DISEASE CARRIER; DRUG FATALITY; EPIDEMIC; HISTORY OF MEDICINE; HUMAN; LETHALITY; NOTE; PRIORITY JOURNAL; VACCINATION; VACCINATION REACTION; VIRUS TRANSMISSION; VIRUS VIRULENCE; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

EID: 50449097068     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.8.960     Document Type: Note

References (15)

1. Reed W, Carroll J, Agramonte A. The etiology of yellow fever: an additional note. JAMA. 1901;36:431-440.
2. Carter HR. Yellow Fever: An Epidemiological and Historical Study of Its Place of Origin. Baltimore, MD: Williams & Wilkins; 1931.
3. Strode GK, Bugher JC, et al, eds. Yellow Fever. New York, NY: McGraw-Hill Book Co; 1951.
4. Bryan CS, Moss SW, Kahn RJ. Yellow fever in the Americas. Infect Dis Clin North Am. 2004;18(2):275-292.
5. Soper FL. The newer epidemiology of yellow fever. Am J Public Health Nations Health. 1937;27(1):1-14.
6. Monath TP. Yellow fever: Victor, Victoria? conqueror, conquest? epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg. 1991;45(1):1-43.
7. Haddow AJ. Yellow fever in central Uganda, 1964, part I: historical introduction. Trans R Soc Trop Med Hyg. 1965;59:436-440.
8. Germain M, Cornet M, Herve JP, et al. Recent advances in research regarding sylvatic yellow fever in West and Central Africa. Bull Inst Pasteur. 1982;80:315-325.
9. Theiler M, Downs WG. The Arthropod-Borne Viruses of Vertebrates: An Account of the Rockefeller Foundation Virus Program, 1951-1970. London, UK: Yale Press, Ltd; 1973.
10. Monath TP, Cetron MS, Teuwen DE. Yellow fever. In: Plotkin S, Orenstein WA, Offit P, eds. Vaccines. 5th ed. Philadelphia, PA: Saunders Elsevier; 2008: 959-1056.
11. Rice CM, Lenches EM, Eddy SR, et al. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985; 229(4715):726-730.
12. Lai CJ, Monath TP. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res. 2003;469:509.
13. World Health Organization. Assessment of yellow fever epidemic risk - a decision-making tool for preventive immunization campaigns. Wkly Epidemiol Rec. 2007;82(18):153-160.
14. Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis. 2004;27(5):319-330.
15. Pan American Health Organization. Final statement by the Pan American Health Organization/World Health Organization (PAHO/WHO) on investigation of serious adverse events in Peru following receipt of yellow fever vaccine produced by Bio-Manguinhos, Brazil. http://www.paho.org/English/AD/ DPC/CD/eid-eer-2008-03-27.htm. Posted March 21, 2008. Accessed July 17, 2008.